Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

Researchers inch closer to more precise treatment for patients with type 1 diabetes

Staff Writer
Staff Writer 5 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

A coalition of experts at the University of Copenhagen and the biotech company Gubra have unveiled an insulin molecule capable of self-regulating blood sugar for patients with type 1 diabetes.

The study appeared in Chemistry – A European Journal.

The new findings could prove to be a major step towards ensuring that patients with diabetes receive the exact right amount of insulin.

The insulin molecule was tested on rodents first and demonstrated efficiency for detecting blood sugar is in the body, the regulation it needs, and the release of insulin into the body only to the right amounts needed.

Although the test on rodents was a success, based on the findings, their transition to begin tests on humans is expected to take years and perhaps years additional before it has the potential to become part of everyday life for patients with diabetes.

“We’ve tested the insulin molecule on rats and it has proven itself effective. The next step is to develop the molecule so that it works more rapidly and accurately,” co-author Knud Jensen stated in a news release of the insulin molecule.

“And finally, to test it in humans — a process that can take many years. But it is certainly worth pinning one’s hopes on.”

Photo: ThinkStock

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: glucose, metabolism, diabetes
Staff Writer December 3, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article A remarkable number of children from the Syrian war are still exhibiting psychological complications
Next Article The Drp1 pathway may lead to the development of more effective treatments for Alzheimer’s disease

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?